CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
Simon J. Harrison(Peter MacCallum Cancer Centre), Piers Blombery(The Royal Melbourne Hospital), Hannah G. Kelly(Peter MacCallum Cancer Centre), Marion Eveillard(Nantes Université), Jane Oliaro(The University of Melbourne), Brad Foulk(Janssen (United States)), Ing Soo Tiong(The University of Melbourne), Juliette Eugene-Lamer, Nikoletta Lendvai(Centro de Investigación del Cáncer), José Varela Donato Filho(490 BioTech (United States)), Vicki Plaks(Johnson & Johnson (United States)), Stephen Lade(The University of Texas MD Anderson Cancer Center), Tamia Nguyen(The University of Melbourne), Patrice Chevallier(Hotel Dieu Hospital), Caroline Bodet‐Milin(Inserm), Marzia Rahman(Peter MacCallum Cancer Centre), Sean M. Grimmond(Center for Genomic Science), Denis A. Smirnov(Eon Corporation (United States)), Katherine Li(Janssen (United States)), Erin Lee(Janssen (United States)), Arnob Banerjee(Johnson & Johnson (United States)), Cyrille Touzeau(Centre National de la Recherche Scientifique), Thomas Gastinne(Nantes Université), Loreta Marquez(Janssen (United States)), Nicole M. Haynes(The University of Melbourne), Carolina Lonardi(Janssen (Switzerland)), Rebecca C Abbott(The University of Melbourne), Ana Slaughter(Centro de Investigación del Cáncer), Jeremy Er(The Royal Melbourne Hospital), Benoît Tessoulin(Centre Hospitalier Universitaire de Nantes), Éric Letouzé(Centre National de la Recherche Scientifique), Jordan M. Schecter(Centro de Investigación del Cáncer), William Deraedt(Janssen (Belgium)), Caroline Mayeur‐Rousse, Martin Vogel(Johnson & Johnson (Germany)), Jessica Li(Sana Biotechnology (United States)), Philippe Moreau(Centre National de la Recherche Scientifique), Nicolas Kint(Ghent University Hospital), Tamar Lengil(Johnson & Johnson (United States)), Hao Zhao(Johnson & Johnson (United States)), Nitin Patel(Centro de Investigación del Cáncer), Dong Geng, Yannick Le Bris(Centre National de la Recherche Scientifique)
Cited by 58
Related Papers
Whole genomes redefine the mutational landscape of pancreatic cancer
|Nature|2015|2.7k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k